![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-gr1.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-gr2.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![PDF) Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers PDF) Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers](https://i1.rgstatic.net/publication/320422102_Clinical_performance_of_LOCI-based_tumor_marker_assays_for_tumor_markers_CA_15-3_CA_125_CEA_CA_19-9_and_AFP_in_gynecological_cancers/links/59e4c8bbaca2724cbfe93c93/largepreview.png)
PDF) Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers
![Rapid Isolation and Multiplexed Detection of Exosome Tumor Markers Via Queued Beads Combined with Quantum Dots in a Microarray | SpringerLink Rapid Isolation and Multiplexed Detection of Exosome Tumor Markers Via Queued Beads Combined with Quantum Dots in a Microarray | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40820-019-0285-x/MediaObjects/40820_2019_285_Figa_HTML.png)
Rapid Isolation and Multiplexed Detection of Exosome Tumor Markers Via Queued Beads Combined with Quantum Dots in a Microarray | SpringerLink
![The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients | Anticancer Research The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/35/10/5519/F1.large.jpg)
The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients | Anticancer Research
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-gr3.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-75319-8/MediaObjects/41598_2020_75319_Fig1_HTML.png)
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecologic
![Site-Specific N-Linked Glycosylation Analysis of Human Carcinoembryonic Antigen by Sheathless Capillary Electrophoresis–Tandem Mass Spectrometry | Journal of Proteome Research Site-Specific N-Linked Glycosylation Analysis of Human Carcinoembryonic Antigen by Sheathless Capillary Electrophoresis–Tandem Mass Spectrometry | Journal of Proteome Research](https://pubs.acs.org/cms/10.1021/acs.jproteome.0c00875/asset/images/medium/pr0c00875_0005.gif)
Site-Specific N-Linked Glycosylation Analysis of Human Carcinoembryonic Antigen by Sheathless Capillary Electrophoresis–Tandem Mass Spectrometry | Journal of Proteome Research
![Current Surveillance After Treatment is Not Sufficient for Patients With Rectal Cancer With Negative Baseline CEA in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 6 (2022) Current Surveillance After Treatment is Not Sufficient for Patients With Rectal Cancer With Negative Baseline CEA in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 6 (2022)](https://jnccn.org/view/journals/jnccn/20/6/full-jnccn21441f4.jpg)